These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291 [TBL] [Abstract][Full Text] [Related]
5. [1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A Federico S; Margiotta E; Salmaso V; Pastorin G; Kachler S; Klotz KN; Moro S; Spalluto G Eur J Med Chem; 2018 Sep; 157():837-851. PubMed ID: 30144700 [TBL] [Abstract][Full Text] [Related]
6. Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A Falsini M; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Volpini R; Di Cesare Mannelli L; Ghelardini C; Colotta V Bioorg Chem; 2019 Jun; 87():380-394. PubMed ID: 30913470 [TBL] [Abstract][Full Text] [Related]
7. Exploring the Role of N Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789 [TBL] [Abstract][Full Text] [Related]
9. Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors. Squarcialupi L; Falsini M; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Volpini R; Colotta V Bioorg Med Chem; 2016 Jun; 24(12):2794-808. PubMed ID: 27161878 [TBL] [Abstract][Full Text] [Related]
10. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972 [TBL] [Abstract][Full Text] [Related]
11. 2-Aryladenine derivatives as a potent scaffold for A Areias F; Correia C; Rocha A; Brea J; Castro M; Loza MI; Proença MF; Carvalho MA Bioorg Med Chem; 2019 Aug; 27(16):3551-3558. PubMed ID: 31280999 [TBL] [Abstract][Full Text] [Related]
12. Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study. Federico S; Ciancetta A; Porta N; Redenti S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G J Med Chem; 2014 Jul; 57(14):6210-25. PubMed ID: 24972108 [TBL] [Abstract][Full Text] [Related]
13. Identification of new potent A Wei Y; Wang M; Li Y; Hong Z; Li D; Lin J Eur J Med Chem; 2020 Feb; 187():111936. PubMed ID: 31855793 [TBL] [Abstract][Full Text] [Related]
14. A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts. Zhou X; Teng B; Tilley S; Mustafa SJ Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1668-79. PubMed ID: 24043252 [TBL] [Abstract][Full Text] [Related]
15. Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation. Varano F; Catarzi D; Squarcialupi L; Betti M; Vincenzi F; Ravani A; Varani K; Dal Ben D; Thomas A; Volpini R; Colotta V Eur J Med Chem; 2015; 96():105-21. PubMed ID: 25874336 [TBL] [Abstract][Full Text] [Related]
16. 5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists. Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Simorini F; Salerno S; Sergianni V; Tuccinardi T; Martinelli A; Cosimelli B; Greco G; Novellino E; Ciampi O; Trincavelli ML; Martini C J Med Chem; 2007 Nov; 50(23):5676-84. PubMed ID: 17927167 [TBL] [Abstract][Full Text] [Related]
17. Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity. Varano F; Catarzi D; Falsini M; Dal Ben D; Buccioni M; Marucci G; Volpini R; Colotta V Bioorg Med Chem Lett; 2019 Feb; 29(4):563-569. PubMed ID: 30638876 [TBL] [Abstract][Full Text] [Related]
18. 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives. Areias F; Correia C; Rocha A; Teixeira S; Castro M; Brea J; Hu H; Carlsson J; Loza MI; Proença MF; Carvalho MA Molecules; 2024 May; 29(11):. PubMed ID: 38893418 [TBL] [Abstract][Full Text] [Related]
19. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives. Deb PK; Deka S; Borah P; Abed SN; Klotz KN Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells. Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]